Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital
6 April 2017 (00:00 - 00:00)
Organised by:
About the speaker
Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
8 More presentations in this session
Doctor J. Daigle (Halifax, CA)
Doctor A. Chauca Tapia (Barcelona, ES)
Associate Professor D. Platonov (Tver, RU)
Access the full session
The Event
EuroPrevent 2017
6 April - 8 April 2017
